Literature DB >> 14734443

Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?

Daniel J DeAngelo, Jerome Ritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14734443     DOI： 10.1158/1078-0432.ccr-1218-3

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  MicroRNA 30a Mediated Autophagy and Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients.

Authors:  Nehal A Khalil; Mohammed N Desouky; Iman H Diab; Nahla A M Hamed; Hazem F Mannaa
Journal:  Indian J Hematol Blood Transfus       Date:  2019-12-12       Impact factor: 0.900

Review 2.  A review on various targeted anticancer therapies.

Authors:  Junjie Li; Feng Chen; Marlein Miranda Cona; Yuanbo Feng; Uwe Himmelreich; Raymond Oyen; Alfons Verbruggen; Yicheng Ni
Journal:  Target Oncol       Date:  2012-02-15       Impact factor: 4.493

3.  The transformative journey of chronic myeloid leukemia.

Authors:  Pratap Neelakantan; Adam Mead
Journal:  Int J Hematol Oncol       Date:  2018-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.